Evidence map›Paper›PMID 42868199›Full record

ArticleOncoimmunology2026

Estradiol-associated extracellular signaling in the human breast

Annelie Abrahamsson, Xingyue Wang, Wen Zhong, Charlotta Dabrosin

Abstract read
In one paragraph

Article in Oncoimmunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Annelie AbrahamssonDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Xingyue WangDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Wen ZhongDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Charlotta DabrosinDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-7191-0018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex steroid exposure is a major risk factor for breast cancer initiation and progression through incompletely understood mechanisms. Novel therapeutics for prevention and treatment of estrogen-dependent breast cancer are needed. Cell-cell interactions within the microenvironment contribute to breast cancer progression through extracellular signaling. Here, extracellular proteins were sampled directly from live normal human breast tissue and breast cancers using microdialysis, and 1,101 proteins were quantified. Mechanistic studies were performed in cultured intact normal human breast tissue and mast cells. Findings were validated

Indexed as

Breast NeoplasmsEstradiolMast CellsStromal CellsAnimalsBreastFemaleHumansMiceReceptors, EstrogenSignal TransductionStem Cell FactorTumor MicroenvironmentZebrafishEstradiolReceptors, EstrogenStem Cell Factorinnate immune cellsMicrodialysissex steroidszebrafish

Identifiers

PMID42868199
PMCPMC13671425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.